Want to see HK:0858 full AI Analyst Report?
Extrawell Pharmaceutical Holdings Limited (0858) Ratios
Extrawell Pharmaceutical Holdings Limited Ratios
HK:0858's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, HK:0858's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.04 | 21.91 | 3.45 | 3.13 | 3.03 |
| Quick Ratio | 5.92 | 21.81 | 3.31 | 3.06 | 2.84 |
| Cash Ratio | 2.80 | 1.60 | 1.82 | 2.14 | 2.09 |
| Solvency Ratio | -4.68 | 1.21 | -0.88 | 0.21 | 0.21 |
| Operating Cash Flow Ratio | 0.00 | -0.09 | -0.07 | 0.06 | -0.02 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 31.52M | $ 871.24M | $ 2.86M | $ -492.62M | $ -465.15M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.29 | 0.09 | 0.09 | 0.43 | 0.45 |
| Debt-to-Equity Ratio | 0.45 | 0.11 | 0.11 | 0.80 | 0.91 |
| Debt-to-Capital Ratio | 0.31 | 0.10 | 0.10 | 0.44 | 0.48 |
| Long-Term Debt-to-Capital Ratio | 0.31 | 0.09 | 0.10 | 0.44 | 0.48 |
| Financial Leverage Ratio | 1.57 | 1.14 | 1.16 | 1.88 | 2.02 |
| Debt Service Coverage Ratio | 0.26 | 11.49 | -7.00 | 9.85 | 11.84 |
| Interest Coverage Ratio | -0.37 | -0.40 | -0.35 | -0.71 | -1.40 |
| Debt to Market Cap | 0.83 | 1.29 | 1.69 | 3.82 | 2.86 |
| Interest Debt Per Share | 0.08 | 0.07 | 0.06 | 0.26 | 0.26 |
| Net Debt to EBITDA | -33.08 | 0.25 | -0.21 | 3.18 | 2.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.19% | 39.46% | 48.70% | 42.91% | 50.80% |
| EBIT Margin | -18.88% | 445.30% | -234.24% | 201.90% | 196.90% |
| EBITDA Margin | -3.44% | 460.24% | -219.16% | 213.84% | 213.52% |
| Operating Profit Margin | -18.88% | -16.08% | -11.04% | -15.37% | -24.97% |
| Pretax Profit Margin | -1915.72% | 405.42% | -269.91% | 185.66% | 183.95% |
| Net Profit Margin | -1903.05% | 401.67% | -275.73% | 178.11% | 176.65% |
| Continuous Operations Profit Margin | -1899.32% | 403.31% | -273.51% | 178.81% | 177.33% |
| Net Income Per EBT | 99.34% | 99.08% | 102.16% | 95.93% | 96.03% |
| EBT Per EBIT | 10144.32% | -2521.82% | 2444.21% | -1208.09% | -736.72% |
| Return on Assets (ROA) | -166.80% | 14.59% | -12.66% | 8.95% | 9.91% |
| Return on Equity (ROE) | -261.19% | 16.68% | -14.64% | 16.80% | 19.99% |
| Return on Capital Employed (ROCE) | -1.77% | -0.60% | -0.53% | -0.80% | -1.47% |
| Return on Invested Capital (ROIC) | -1.76% | -0.60% | -0.53% | -0.80% | -1.46% |
| Return on Tangible Assets | -167.32% | 14.60% | -12.68% | 8.97% | 9.94% |
| Earnings Yield | -494.01% | 207.01% | -235.10% | 80.73% | 62.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.79 | 1.35 | 1.12 | 12.52 | 9.46 |
| Payables Turnover | 7.25 | 7.58 | 6.51 | 6.25 | 5.63 |
| Inventory Turnover | 5.87 | 7.08 | 4.17 | 10.56 | 2.88 |
| Fixed Asset Turnover | 0.42 | 0.46 | 0.47 | 0.53 | 0.50 |
| Asset Turnover | 0.09 | 0.04 | 0.05 | 0.05 | 0.06 |
| Working Capital Turnover Ratio | 0.08 | 0.10 | 0.48 | 0.58 | 0.52 |
| Cash Conversion Cycle | 142.71 | 272.99 | 356.04 | 5.28 | 100.56 |
| Days of Sales Outstanding | 130.90 | 269.61 | 324.64 | 29.15 | 38.58 |
| Days of Inventory Outstanding | 62.13 | 51.53 | 87.46 | 34.57 | 126.78 |
| Days of Payables Outstanding | 50.32 | 48.15 | 56.06 | 58.44 | 64.79 |
| Operating Cycle | 193.03 | 321.14 | 412.10 | 63.72 | 165.35 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Free Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -1.43 | -3.07 | 0.49 | -0.17 |
| Capital Expenditure Coverage Ratio | 0.00 | -1.43 | -3.07 | 0.49 | -0.17 |
| Operating Cash Flow Coverage Ratio | 0.00 | -0.03 | -0.03 | 0.01 | -0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | -0.08 | -0.06 | 0.04 | -0.02 |
| Free Cash Flow Yield | 0.00% | -6.92% | -7.06% | -2.13% | -5.40% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.20 | 0.48 | -0.43 | 1.24 | 1.59 |
| Price-to-Sales (P/S) Ratio | 3.85 | 1.94 | 1.17 | 2.21 | 2.81 |
| Price-to-Book (P/B) Ratio | 0.53 | 0.08 | 0.06 | 0.21 | 0.32 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | -14.45 | -14.17 | -47.06 | -18.52 |
| Price-to-Operating Cash Flow Ratio | 0.00 | -24.59 | -18.79 | 49.82 | -130.04 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | 0.00 | -1.35 | -0.01 |
| Enterprise Value Multiple | -144.93 | 0.67 | -0.74 | 4.21 | 4.26 |
| Enterprise Value | 256.97M | 170.72M | 96.11M | 653.51M | 671.98M |
| EV to EBITDA | -144.93 | 0.67 | -0.74 | 4.21 | 4.26 |
| EV to Sales | 4.99 | 3.08 | 1.63 | 9.00 | 9.09 |
| EV to Free Cash Flow | 0.00 | -22.94 | -19.65 | -192.04 | -59.85 |
| EV to Operating Cash Flow | 0.00 | -39.03 | -26.05 | 203.33 | -420.25 |
| Tangible Book Value Per Share | 0.15 | 0.56 | 0.46 | 0.32 | 0.27 |
| Shareholders’ Equity Per Share | 0.15 | 0.56 | 0.47 | 0.32 | 0.27 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.01 | -0.01 | 0.01 | 0.01 |
| Revenue Per Share | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Net Income Per Share | -0.40 | 0.09 | -0.07 | 0.05 | 0.05 |
| Tax Burden | 0.99 | 0.99 | 1.02 | 0.96 | 0.96 |
| Interest Burden | 101.44 | 0.91 | 1.15 | 0.92 | 0.93 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| SG&A to Revenue | 0.63 | 0.56 | 0.37 | 0.35 | 0.33 |
| Stock-Based Compensation to Revenue | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.00 | -0.02 | 0.02 | 0.02 | -0.01 |
Currency in HKD
